azosemide has been researched along with Chronic Disease in 7 studies
azosemide : A sulfonamide that is benzenesulfonamide which is substituted at positions 2, 4, and 5 by chlorine, (2-thienylmethyl)amino and 1H-tetrazol-5-yl groups, respectively. It is a diuretic that has been used in the management of oedema and hypertension.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have previously reported that a long-acting loop diuretic, azosemide, reduces cardiovascular risks in patients with chronic heart failure (CHF) as compared with a short-acting one, furosemide, in Japanese Multicenter Evaluation of LOng- versus short-acting Diuretics In Congestive heart failure (J-MELODIC)." | 5.24 | Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis. ( Akasaka, T; Daimon, T; Fukui, M; Hirano, Y; Hirotani, S; Ito, H; Kawabata, M; Masuyama, T; Nakatani, S; Ohte, N; Tsujino, T; Yamamoto, K, 2017) |
| "We investigated the effects of a short-acting loop diuretic (furosemide) and a long-acting loop diuretic (azosemide) on heart rate variability, fluid balance, and neurohormonal responses in patients with mild to moderate chronic congestive heart failure." | 5.09 | Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure. ( Doba, N; Imai, Y; Nakayama, T; Sakuma, Y; Shiojima, K; Tomiyama, H; Watanabe, G; Yamamoto, A; Yoshida, H, 1999) |
| "We evaluated the comparative effects of furosemide, a short-acting loop diuretic, and azosemide, a long-acting loop diuretic, on neurohumoral factors and quality of life (QOL) in patients with congestive heart failure (CHF)." | 3.71 | Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure. ( Kinoshita, M; Maeda, K; Tsutamoto, T; Tsutsui, T, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, M | 1 |
| Tsujino, T | 2 |
| Hirotani, S | 1 |
| Ito, H | 2 |
| Yamamoto, K | 2 |
| Akasaka, T | 2 |
| Hirano, Y | 2 |
| Ohte, N | 2 |
| Daimon, T | 2 |
| Nakatani, S | 2 |
| Kawabata, M | 1 |
| Masuyama, T | 2 |
| Hisatake, S | 1 |
| Nanjo, S | 1 |
| Fujimoto, S | 1 |
| Yamashina, S | 1 |
| Yuzawa, H | 1 |
| Namiki, A | 1 |
| Nakano, H | 1 |
| Yamazaki, J | 1 |
| Miyata, M | 1 |
| Sasaki, T | 1 |
| Ikeda, Y | 1 |
| Shinsato, T | 1 |
| Kubozono, T | 1 |
| Furusho, Y | 1 |
| Kusumoto, A | 1 |
| Hamasaki, S | 1 |
| Tei, C | 1 |
| Origasa, H | 1 |
| Tomiyama, H | 1 |
| Nakayama, T | 1 |
| Watanabe, G | 1 |
| Shiojima, K | 1 |
| Sakuma, Y | 1 |
| Yamamoto, A | 1 |
| Imai, Y | 1 |
| Yoshida, H | 1 |
| Doba, N | 1 |
| Tsutsui, T | 1 |
| Tsutamoto, T | 1 |
| Maeda, K | 1 |
| Kinoshita, M | 1 |
| Yamamoto, T | 1 |
| Kimura, T | 1 |
| Ota, K | 1 |
| Iitake, K | 1 |
| Shoji, M | 1 |
| Inoue, M | 1 |
| Sato, K | 1 |
| Ohta, M | 1 |
| Yoshinaga, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Japanese Multicenter Evaluation of Long- Versus Short-acting Diuretics in Congestive Heart Failure[NCT00355667] | Phase 4 | 320 participants (Actual) | Interventional | 2006-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for azosemide and Chronic Disease
| Article | Year |
|---|---|
Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.
Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Echocardiography; Female; Furosemide; Heart Fa | 2017 |
Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Cross-Over Studies; Female; | 2011 |
Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF).
Topics: Aged; Atrial Natriuretic Factor; Biomarkers; Chronic Disease; Delayed-Action Preparations; Echocardi | 2012 |
Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.
Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Chronic Disease; Disease-Free Survival; Female; Fu | 2012 |
Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure.
Topics: Blood Pressure; Cardiac Output; Chronic Disease; Cross-Over Studies; Diuretics; Echocardiography, Do | 1999 |
2 other studies available for azosemide and Chronic Disease
| Article | Year |
|---|---|
Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure.
Topics: Administration, Oral; Aged; Chi-Square Distribution; Chronic Disease; Diuretics; Dosage Forms; Femal | 2001 |
[A case of chronic syndrome of inappropriate secretion of antidiuretic hormone (SIADH) due to traumatic subarachnoidal hemorrhage: its treatment with azosemide].
Topics: Chronic Disease; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Skull Fractures; Sodium Chlo | 1989 |